Kataoka Kozo, Katai Hitoshi, Mizusawa Junki, Katayama Hiroshi, Nakamura Kenichi, Morita Shinji, Yoshikawa Takaki, Ito Seiji, Kinoshita Takahiro, Fukagawa Takeo, Sasako Mitsuru
JCOG Data Center/Operations Office, National Cancer Center, Japan.
Gastric Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
J Gastric Cancer. 2016 Jun;16(2):93-7. doi: 10.5230/jgc.2016.16.2.93. Epub 2016 Jun 24.
Several prospective studies on laparoscopy-assisted distal gastrectomy for early gastric cancer have been initiated, but no prospective study evaluating laparoscopy-assisted total gastrectomy or laparoscopy-assisted proximal gastrectomy has been completed to date. A non-randomized confirmatory trial was commenced in April 2015 to evaluate the safety of laparoscopy-assisted total gastrectomy and laparoscopy-assisted proximal gastrectomy for clinical stage I gastric cancer. A total of 245 patients will be accrued from 42 Japanese institutions over 3 years. The primary endpoint is the proportion of patients with anastomotic leakage. The secondary endpoints are overall survival, relapse-free survival, proportion of patients with completed laparoscopy-assisted total gastrectomy or laparoscopy-assisted proximal gastrectomy, proportion of patients with conversion to open surgery, adverse events, and short-term clinical outcomes. The UMIN Clinical Trials Registry number is UMIN000017155.
已经开展了多项关于腹腔镜辅助远端胃癌切除术治疗早期胃癌的前瞻性研究,但迄今为止,尚无评估腹腔镜辅助全胃切除术或腹腔镜辅助近端胃切除术的前瞻性研究完成。2015年4月开始了一项非随机验证性试验,以评估腹腔镜辅助全胃切除术和腹腔镜辅助近端胃切除术治疗临床I期胃癌的安全性。将在3年内从42家日本机构招募245例患者。主要终点是吻合口漏患者的比例。次要终点包括总生存期、无复发生存期、完成腹腔镜辅助全胃切除术或腹腔镜辅助近端胃切除术的患者比例、转为开放手术的患者比例、不良事件以及短期临床结局。该研究在UMIN临床试验注册中心的注册号为UMIN000017155。